Hologic HOLX - News Analyzed: 3,835 - Last Week: 100 - Last Month: 500

Hologic Inc. (HOLX) has been a topic of extensive coverage lately. The company continues to present a strong momentum for the long-term with the stock near its 52-week high. Prudential PLC has taken notice and raised its holdings, while Andra AP fonden and Nuance Investments LLC have significant stock holdings. Despite the stock taking a dip, it has still surpassed Q3 earnings and revenue estimates and has subsequently been upgraded to a strong-buy by StockNews.com. The third quarter of fiscal 2024 showed increased earnings and revenues, however, this was not without challenges.

Deeper analysis of the company reveals its fiscal Q1 2024 earnings surpassed company guidance and lead to an updated full-year outlook. Q3 earnings featured strong revenue and EPS growth, surpassing analyst estimates. Moreover, Hologic is slated to acquire Endomagnetics Ltd, a breast surgical guidance company. Zacks Research has revised their earning estimates upwards. Additionally, Hologic signed bigger M&A deals after it overcame chip shortage. New additions to its board of directors include Nanaz Mohtashami and Stacey D. Stewart.

In recent news, HOLX is considering the acquisition of Bolder Surgical and it launched the three-in-one Omni Hysteroscope while also opening an innovation center in France.

Hologic HOLX News Analytics from Tue, 25 Mar 2014 07:00:00 GMT to Sat, 14 Sep 2024 13:30:30 GMT - Rating 8 - Innovation 7 - Information 8 - Rumor -2